News | June 25, 2024
Venus Remedies clinches WHO-backed PAHO tender
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Combined entity is better positioned to compete in increasingly competitive generics industry
PEKK is a high-performance polymer family used in aerospace and other demanding markets
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Renews GMP certifications for India and Malaysia sites
The company will now explore a buyer for its manufacturing site and exit in due course
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Subscribe To Our Newsletter & Stay Updated
